Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.
Press releases published on April 22, 2025
Midland Announces the Acquisition of the Kan Gold Project in the Labrador Trough
GlobeNewswire
·
April 22, 2025
MONTREAL, April 22, 2025 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the acquisition of 100% interest in the Kan gold project from a private company (Ressources Tectonic). The Kan project is located in the …
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
GlobeNewswire
·
April 22, 2025
CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO …
Emerita Intersects 10.8 Meters Grading 4.8% Copper, 1.4 g/t Gold and 8.9 Meters Grading 1.1% Copper, 1.2 g/t Gold at El Cura Deposit
GlobeNewswire
·
April 22, 2025
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) continues to intersect copper-gold mineralization with associated zinc-lead-silver at its ongoing drilling campaign at …
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
GlobeNewswire
·
April 22, 2025
Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses pacemaker-indicated patients with uncontrolled hypertension …
Rapport Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 22, 2025
BOSTON and SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire
·
April 22, 2025
TORONTO and HOUSTON, April 22, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …
Newcore Gold Drilling Intersects 2.50 g/t Gold over 15.0 Metres and 3.00 g/t Gold over 10.0 metres at the Enchi Gold Project, Ghana
GlobeNewswire
·
April 22, 2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce additional drill results from the 35,000-metre drill program underway at the Company’s 100% …
Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025
GlobeNewswire
·
April 22, 2025
Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral Rinse Phase 2a Study Now Fully Enrolled Across All Three Dose Cohorts Advancing Toward Phase 2b IND Submission and Broader Regulatory Engagement …
Fortuna to release first quarter 2025 financial results on May 7, 2025; Conference call at 12 p.m. Eastern time on May 8, 2025
GlobeNewswire
·
April 22, 2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announces that it will release its financial statements and MD…
Telix Reports US$186M Q1 Revenue, Up 62% YOY
GlobeNewswire
·
April 22, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 March 2025 ( …
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
GlobeNewswire
·
April 22, 2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new drug discoveries, is pleased to announce the successful …
Integral Metals Welcomes Shervin Pishevar as an Advisor to the Company
GlobeNewswire
·
April 22, 2025
CALGARY, Alberta, April 22, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the addition of Shervin Pishevar as an Advisor to the Company. With his extensive experience …
HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China
GlobeNewswire
·
April 22, 2025
HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in …
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
GlobeNewswire
·
April 22, 2025
San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported that it received notice from the NYSE …